Mass Tort News
6 min read
Dupixent CTCL Lawsuits: The Next Emerging MDL
Plaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.
Read
Mass Tort News Articles
18 articles in this category
Mass Tort News
6 min read
Mass Tort News
6 min read
ByHeart Formula Botulism Cases Become MDL-3178
The first formula-linked infant botulism outbreak—48 cases across 19 states—is now a federal MDL in New York.
Read
Mass Tort News
6 min read
Mass Tort News
7 min read
Mass Tort News
6 min read
Roundup Settlement: $7.25B Deal Approved
Missouri judge grants preliminary approval for Bayer's $7.25B Roundup class settlement covering 65,000 cancer claims.
Read
Mass Tort News
7 min read
MDL Trends Q1 2026: Where the Cases Are
158 active MDLs, 197,965 pending cases, and 95% concentrated in the top 25 dockets. A Q1 2026 mass tort landscape snapshot.
Read
Mass Tort News
6 min read
Hair Relaxer Lawsuits Hit 11,000: 2026 Update
MDL-3060 adds 247 cases per month. Daubert motions due April 1 as bellwether trials approach for 2027.
Read
Mass Tort News
6 min read
Camp Lejeune 2026: $530M Paid, Trials Begin
The Navy has paid $530M across 2,000 offers with 90% acceptance. But 409,000 claims remain pending as bellwether trials approach.
Read
Mass Tort News
6 min read
NEC Formula Lawsuits: Trials Resume Aug 2026
Second-wave bellwether trials set after $495M state verdict. Federal judge schedules three new test cases through Feb 2027.
Read
Mass Tort News
6 min read
Paraquat Lawsuits 2026: What Firms Need to Know
Syngenta settled the first paraquat-Parkinson's trial hours before it began. 6,400 federal cases await resolution.
Read
Mass Tort News
6 min read
Mass Tort News
7 min read
OCR settlement underscores HIPAA 30-day record access
HHS OCR’s Concentra settlement highlights HIPAA’s 30-day access deadline, fee limits, and what patients can do when providers delay medical records.
Read
Mass Tort News
8 min read
Mass Tort News
7 min read
Depo-Provera Litigation: FDA Warning Reshapes MDL as Cases Surpass 2,100
FDA adds meningioma warning to Depo-Provera label as MDL 3140 surpasses 2,100 cases. First bellwether trial set for December 2026.
Read
Mass Tort News
10 min read
Ozempic Litigation Comprehensive Guide: August 2025 Updates and Medical Record Challenges
Complete guide to Ozempic litigation including Judge Marston's landmark ruling, NAION vision loss claims, and how law firms are managing the medical record challenges with 2,190+ cases in MDL 3094.
Read
Mass Tort News
9 min read
Social Media Addiction Litigation Update: July 2025 MDL Progress and Bellwether Trial Preparations
Comprehensive overview of the social media addiction MDL developments, including the first bellwether trials, algorithmic liability theories, and what law firms need to know about representing affected families.
Read
Mass Tort News
8 min read
Camp Lejeune Litigation Update: July 2025 Developments and the Medical Records Challenge
Latest Camp Lejeune litigation updates including court rulings, settlement progress, and how law firms are tackling the critical medical records challenge with nearly 500,000 claims filed.
Read